Access to and funding of clinical trials in Belgium

Date: Friday 25 November 2024, from 2:00 pm. until 6:00 p.m. (followed by a reception)

Address: Brederodestraat 13, 1000 Bruxelles (The conference room is kindly offered by the lawfirm Linklaters)

Part 1: Setting the scene

14:30 - Welcoming words - Delphine Heenen (Kicker-in-Chief, KickCancer)

14:40 - Patient testimonial - TBC (Patients)

Part 2: Funding of "standard of care" clinical trials

14:50 - Inclusion of patients in frontline clinical trials as standard of care - Bram De Wilde (Paediatric oncologist, UZ Gent, Belgium)

15:05 - State of play of funding system in Belgium - Pierre Mayeur (Chief Executive Officer, BSPHO, Belgium)

15:20 - Foreign examples - TBC (Paediatric oncologists)

15:40 - Panel discussion and Q&A

16:10 - Break

Part 3: Access to clinical trials

16:25 - State of play in Belgium: current fallouts - An Van Damme (Paediatric Oncologist, CUSL, Belgium)

16:35 - S2 forms - Entitlement to scheduled treatment - TBC

16:50 - Non-governmental organisations' role - TBC (Representative of a patient organisation)

17:00 - Foreign examples - TBC (Paediatric oncologists)

17:20 - Panel discussion and Q&A

17:50 - Closing remarks - Delphine Heenen (Kicker-in-Chief, KickCancer)

18:00 - Cocktail

19:00 - End